June 2016

The PI3K protein: a potential new therapeutic target in pancreatic neuroendocrine tumors

Researchers from the Institute of Biomedical Investigation of Bellvitge (IDIBELL) have demonstrated that selective inactivation of the p110α PI3K isoform is sufficient to block tumor progression and metastasis in a mice model of PanNETs.

The PI3K protein: a potential new therapeutic target in pancreatic neuroendocrine tumors Read More »

Scroll to Top